Researchers have identified MX1, GPR84, and E2F2 as potential LN biomarkers through transcriptome sequencing analysis of PBMC samples from patients, which are highly expressed in LN and lowly expressed in patients with non-LN SLE with high specificity (15). Here, MX1 is linked to systemic lupus erythematosus.